Use

NeoTYPE® DNA & RNA - Brain uses targeted next-generation sequencing (NGS) to detect single nucleotide variants, insertions/deletions, and gene fusions in 83 unique genes total (62 DNA, 28 RNA; overlapping targets included), plus microsatellite instability (MSI) and tumor mutational burden (TMB). Results provide diagnostic, prognostic, and therapeutic implications, as well as potential clinical trial options. Potential reflex testing for MSI by PCR is performed if MSI NGS results are indeterminate and conditions are met.